18 November 2023>: Articles
Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series
Unusual or unexpected effect of treatment
John P. Palmer A* , Arief A. Suriawinata B , Shaofeng Yan B , Darcy A. Kerr B , Muhammad Z. Afzal A , Keisuke Shirai ADOI: 10.12659/AJCR.938537
Am J Case Rep 2023; 24:e938537
Figure 18. Case 6: (A) A parotid biopsy shows melanoma present as loosely clustered malignant cells with nuclear hyperchromasia and amphophilic cytoplasm (hematoxylin and eosin [H&E], original magnification ×200). (B) Subsequent parotid resection demonstrates metastatic melanoma (upper right portion of image) involving an intraparotid lymph node (H&E, ×200). (C) A lung biopsy shows metastatic melanoma with similar morphologic features (H&E, ×200) and (D) diffuse SOX10 reactivity (immunohistochemistry, ×200). (E) The subsequent lung wedge resection specimen demonstrates extensive treatment effect with sheets of melanophages without histologically viable tumor cells (H&E ×200). (F) A special stain for melanin highlights these melanin-containing histiocytes (Fontana Masson, ×200).